Published by Iain Gilbert on 13th June 2025
(Sharecast News) - Drugmaker GSK said on Friday that its RSV vaccine, Arexvy, has been accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and older.
URL: http://www.digitallook.com/dl/news/story/35148239/...